Enhanced repair of extensive articular defects by insulin‐like growth factor‐I‐laden fibrin composites

Stem cells indigenous to the cancellous spaces of the bone bed in an acute injury provide an important source of pluripotent cells for cartilage repair. Insulin‐like growth factor‐I facilitates chondrogenesis of bone marrow‐derived stem cells in long‐term culture and may enhance chondrogenesis in healing cartilage lesions in vivo. This study examined the impact of insulin‐like growth factor‐I, gradually released from fibrin clots polymerized in situ, on the recruitable stem‐cell pool in a full‐thickness critical cartilage defect model. Twelve full‐thickness 15‐mm cartilage lesions in the femoropatellar articulations of six young mature horses were repaired by an injection of autogenous fibrin containing 25 μg of human recombinant insulin‐like growth factor‐I or, in control joints, fibrin without the growth factor. All horses were killed at 6 months, and cartilage repair tissue and surrounding cartilage were assessed by histology, histochemistry, types I and II collagen immunohistochemistry, types I and II collagen in situ hybridization, and matrix biochemical determinations. White tissue filled grafted and control lesions, with the growth factor‐treated defects being more completely filled and securely attached to the subchondral bone. A moderately improved chondrocyte population, more columnar cellular organization, and better attachment to the underlying bone were evident on histological evaluation of growth factor‐treated defects. Type‐II procollagen mRNA was abundantly present in the deeper half of the treated sections compared with moderate message expression in control tissues. Immunolocalization of type‐II collagen showed a preponderance of the collagen in growth factor‐treated lesions, confirming translation of type‐II message to protein. Composite histologic healing scores for treated defects were significantly improved over those for control defects. DNA content in the cartilage defects was similar in treated and control joints. Matrix proteoglycan content was similar in treated and control defects and lower in the defects than in the intact surrounding and remote cartilage of the treated and control joints. The proportion of type‐II collagen significantly increased in growth factor‐treated tissues. Fibrin polymers laden with insulin‐like growth factor‐I improved the histologic appearance and the proportion of type‐II collagen in healing, full‐thickness cartilage lesions. However, none of the biochemical or morphologic features were consistent with those of normal articular cartilage.

[1]  A. Nixon,et al.  Disparate chondrocyte metabolism in three-dimensional fibrin cultures derived from autogenous or commercially manufactured fibrinogen. , 1998, American journal of veterinary research.

[2]  Nixon Aj,et al.  Insulin-like growth factor I peptide elution profiles from fibrin polymers determined by use of high-performance liquid chromatography. , 1997 .

[3]  E. Morris,et al.  The Effect of Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2) on the Healing of Full-Thickness Defects of Articular Cartilage* , 1997, The Journal of bone and joint surgery. American volume.

[4]  C. Sledge,et al.  Effect of Cultured Autologous Chondrocytes on Repair of Chondral Defects in a Canine Model* , 1997, The Journal of bone and joint surgery. American volume.

[5]  M. Pitman,et al.  Chondrocyte transplantation using a collagen bilayer matrix for cartilage repair. , 1997, The Journal of bone and joint surgery. British volume.

[6]  J. Buckwalter,et al.  Age‐related decline in chondrocyte response to insulin‐like growth factor‐I: The role of growth factor binding proteins , 1997, Journal of Orthopaedic Research.

[7]  Tom Minas,et al.  Current concepts in the treatment of articular cartilage defects. , 1997, Orthopedics.

[8]  E. Schönau,et al.  Elevated levels of insulin-like growth factor (IGF) binding protein-3 in rheumatoid arthritis synovial fluid inhibit stimulation by IGF-I of articular chondrocyte proteoglycan synthesis , 1997, Rheumatology International.

[9]  W. Salmon,et al.  Stimulation of sulfate and thymidine incorporation into hypophysectomized rat cartilage by growth hormone and insulin-like growth factor-I in vitro: the somatomedin hypothesis revisited. , 1997, The Journal of laboratory and clinical medicine.

[10]  M. Brittberg,et al.  Influence of fibrin sealant (Tisseel) on osteochondral defect repair in the rabbit knee. , 1997, Biomaterials.

[11]  J. Pelletier,et al.  Normal expression of type 1 insulin-like growth factor receptor by human osteoarthritic chondrocytes with increased expression and synthesis of insulin-like growth factor binding proteins. , 1996, Arthritis and rheumatism.

[12]  C. Ohlsson,et al.  Rabbit Articular Cartilage Defects Treated With Autologous Cultured Chondrocytes , 1996, Clinical orthopaedics and related research.

[13]  E. Hunziker,et al.  Repair of Partial-Thickness Defects in Articular Cartilage: Cell Recruitment from the Synovial Membrane* , 1996, The Journal of bone and joint surgery. American volume.

[14]  W. Maloney,et al.  Chondrocytes from osteoarthritic cartilage have increased expression of insulin-like growth factor I (IGF-I) and IGF-binding protein-3 (IGFBP-3) and -5, but not IGF-II or IGFBP-4. , 1996, The Journal of clinical endocrinology and metabolism.

[15]  J. Vacanti,et al.  De Novo Cartilage Generation Using Calcium Alginate‐Chondrocyte Constructs , 1996, Plastic and reconstructive surgery.

[16]  R. Schneiderman,et al.  Insulin-like growth factor-I and its complexes in normal human articular cartilage: studies of partition and diffusion. , 1995, Archives of biochemistry and biophysics.

[17]  J. van Marle,et al.  Chondrocyte IGF-1 receptor expression and responsiveness to IGF-1 stimulation in mouse articular cartilage during various phases of experimentally induced arthritis. , 1995, Annals of the rheumatic diseases.

[18]  P. Guerne,et al.  Growth factor responsiveness of human articular chondrocytes in aging and development. , 1995, Arthritis and rheumatism.

[19]  A. Nixon,et al.  Local and remote matrix responses to chondrocyte-laden collagen scaffold implantation in extensive articular cartilage defects. , 1995, Osteoarthritis and cartilage.

[20]  A. Nixon,et al.  Chondrocyte-laden collagen scaffolds for resurfacing extensive articular cartilage defects. , 1995, Osteoarthritis and cartilage.

[21]  T. I. Morales.  Transforming growth factor-beta and insulin-like growth factor-1 restore proteoglycan metabolism of bovine articular cartilage after depletion by retinoic acid. , 1994, Archives of biochemistry and biophysics.

[22]  C. Ohlsson,et al.  Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. , 1994, The New England journal of medicine.

[23]  A. Reddi.  Symbiosio of biotechnology and biomaterials: Applications in tissue engineering of bone and cartilage , 1994, Journal of cellular biochemistry.

[24]  L. Sandell,et al.  In situ expression of collagen and proteoglycan genes in notochord and during skeletal development and growth , 1994, Microscopy research and technique.

[25]  R Langer,et al.  Joint resurfacing using allograft chondrocytes and synthetic biodegradable polymer scaffolds. , 1994, Journal of biomedical materials research.

[26]  R J Todhunter,et al.  Chondrocyte‐fibrin matrix transplants for resurfacing extensive articular cartilage defects , 1994, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[27]  J. Vacanti,et al.  Joint Resurfacing with Cartilage Grown in Situ from Cell-Polymer Structures , 1994, The American journal of sports medicine.

[28]  Joseph M. Mansour,et al.  Mesenchymal Cell-Based Repair of Large Full Thickness Defects of Articular Cartilage , 1994 .

[29]  E. Hunziker,et al.  Differential effects of insulin-like growth factor I and growth hormone on developmental stages of rat growth plate chondrocytes in vivo. , 1994, The Journal of clinical investigation.

[30]  G. Lust,et al.  Phenotype and biological activity of neonatal equine chondrocytes cultured in a three-dimensional fibrin matrix. , 1994, American journal of veterinary research.

[31]  J. Pelletier,et al.  Human osteoarthritic chondrocytes possess an increased number of insulin-like growth factor 1 binding sites but are unresponsive to its stimulation. Possible role of IGF-1-binding proteins. , 1994, Arthritis and rheumatism.

[32]  W. B. van den Berg,et al.  Insulin-like growth factor stimulation of articular chondrocyte proteoglycan synthesis. Availability and responses at different ages. , 1993, British journal of rheumatology.

[33]  K. Takaoka,et al.  Polylactic acid-polyethylene glycol block copolymer. A new biodegradable synthetic carrier for bone morphogenetic protein. , 1993, Clinical orthopaedics and related research.

[34]  C. Malemud.  The role of growth factors in cartilage metabolism. , 1993, Rheumatic diseases clinics of North America.

[35]  M J Glimcher,et al.  Cell origin and differentiation in the repair of full-thickness defects of articular cartilage. , 1993, The Journal of bone and joint surgery. American volume.

[36]  R. Altman,et al.  Treatment of canine osteoarthritis with insulin-like growth factor-1 (IGF-1) and sodium pentosan polysulfate. , 1993, Osteoarthritis and cartilage.

[37]  M. Silbermann,et al.  The early postnatal development of the murine mandibular condyle is regulated by endogenous insulin-like growth factor-I. , 1993, The Journal of endocrinology.

[38]  D. Schoenfeld,et al.  Regulation of growth-plate chondrocytes by insulin-like growth-factor I and basic fibroblast growth factor. , 1993, The Journal of bone and joint surgery. American volume.

[39]  R. Warren,et al.  The repair of osteochondral defects using an exogenous fibrin clot , 1992, The American journal of sports medicine.

[40]  H. Ohtsu,et al.  Induction of swelling, synovial hyperplasia and cartilage proteoglycan loss upon intra-articular injection of transforming growth factor beta-2 in the rabbit. , 1992, Cytokine.

[41]  N. Kawabe,et al.  The repair of full-thickness articular cartilage defects. Immune responses to reparative tissue formed by allogeneic growth plate chondrocyte implants. , 1991, Clinical orthopaedics and related research.

[42]  N. Olsen,et al.  Transforming growth factor beta 1 (TGF-beta 1) induced neutrophil recruitment to synovial tissues: implications for TGF-beta-driven synovial inflammation and hyperplasia , 1991, The Journal of experimental medicine.

[43]  R. Langer,et al.  Future directions in biomaterials. , 1990, Biomaterials.

[44]  M. McGrath,et al.  Peptide growth factors and wound healing. , 1990, Clinics in plastic surgery.

[45]  B. Carlsson,et al.  Regulation by GH of insulin-like growth factor-I mRNA expression in rat epiphyseal growth plate as studied with in-situ hybridization. , 1990, The Journal of endocrinology.

[46]  S. Wahl,et al.  Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor beta , 1990, The Journal of experimental medicine.

[47]  L. Joosten,et al.  CHONDROCYTE NONRESPONSIVENESS TO INSULIN‐LIKE GROWTH FACTOR 1 IN EXPERIMENTAL ARTHRITIS , 1989, Arthritis and rheumatism.

[48]  J. Tyler.  Insulin-like growth factor 1 can decrease degradation and promote synthesis of proteoglycan in cartilage exposed to cytokines. , 1989, The Biochemical journal.

[49]  L. Peterson,et al.  The repair of experimentally produced defects in rabbit articular cartilage by autologous chondrocyte transplantation , 1989, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[50]  F. Luyten,et al.  Insulin-like growth factors maintain steady-state metabolism of proteoglycans in bovine articular cartilage explants. , 1988, Archives of biochemistry and biophysics.

[51]  A. Grodzinsky,et al.  Fluorometric assay of DNA in cartilage explants using Hoechst 33258. , 1988, Analytical biochemistry.

[52]  A. Lindahl,et al.  Growth hormone in vivo potentiates the stimulatory effect of insulin-like growth factor-1 in vitro on colony formation of epiphyseal chondrocytes isolated from hypophysectomized rats. , 1987, Endocrinology.

[53]  A. Abramovici,et al.  Use of cultured embryonal chick epiphyseal chondrocytes as grafts for defects in chick articular cartilage. , 1987, Clinical orthopaedics and related research.

[54]  D. Buttle,et al.  Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. , 1986, Biochimica et biophysica acta.

[55]  E. Froesch,et al.  Human fetal and adult chondrocytes. Effect of insulinlike growth factors I and II, insulin, and growth hormone on clonal growth. , 1986, The Journal of clinical investigation.

[56]  M. Tiku,et al.  Class II histocompatibility antigen-mediated immunologic function of normal articular chondrocytes. , 1985, Journal of immunology.

[57]  B. Bidlingmeyer,et al.  Rapid analysis of amino acids using pre-column derivatization. , 1984, Journal of chromatography.

[58]  F. N. Ghadially,et al.  Ultrastructural observations on surgically produced partial-thickness defects in articular cartilage. , 1972, Clinical orthopaedics and related research.

[59]  S. Heyner.  THE SIGNIFICANCE OF THE INTERCELLULAR MATRIX IN THE SURVIVAL OF CARTILAGE ALLOGRAFTS , 1969, Transplantation.

[60]  T. Aigner,et al.  Transplantation of allograft chondrocytes embedded in agarose gel into cartilage defects of rabbits. , 1998, Osteoarthritis and cartilage.

[61]  M. Müller,et al.  Removal of proteoglycans from the surface of defects in articular cartilage transiently enhances coverage by repair cells. , 1998, The Journal of bone and joint surgery. British volume.

[62]  E. Hunziker,et al.  Removal of proteoglycans from the surface of defects in articular cartilage transiently enhances coverage by repair cells , 1998 .

[63]  C. Sledge,et al.  Healing of chondral and osteochondral defects in a canine model: the role of cultured chondrocytes in regeneration of articular cartilage. , 1996, Biomaterials.

[64]  A. Oberbauer,et al.  Growth hormone and IGF-I stimulate cell function in distinct zones of the rat epiphyseal growth plate. , 1995, Connective tissue research.

[65]  R. Manji,et al.  Repair of articular cartilage defects using mesenchymal stem cells. , 1995, Tissue engineering.

[66]  D. Hill,et al.  Peptide growth factors and their interactions during chondrogenesis. , 1992, Progress in growth factor research.

[67]  D. Hill.  Peptide growth factor interactions in embryonic and fetal growth. , 1992, Hormone research.

[68]  E. Thonar,et al.  Age-related differences in the metabolism of proteoglycans in bovine articular cartilage explants maintained in the presence of insulin-like growth factor I. , 1991, Connective tissue research.

[69]  T Ochi,et al.  Repair of rabbit articular surfaces with allograft chondrocytes embedded in collagen gel. , 1989, The Journal of bone and joint surgery. British volume.

[70]  L. Joosten,et al.  Insulin-like growth factor stimulation of chondrocyte proteoglycan synthesis by human synovial fluid. , 1989, Arthritis and rheumatism.

[71]  H. Mankin,et al.  Effect of Somatomedin-C/Insulin-Like Growth Factor I and Growth Hormone on Cultured Growth Plate and Articular Chondrocytes , 1989, Pediatric Research.

[72]  M. Glimcher,et al.  Biochemical studies on repair cartilage resurfacing experimental defects in the rabbit knee. , 1980, The Journal of bone and joint surgery. American volume.